Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Compound 4 is a promising treatment for hair loss with low toxicity.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Naringenin and its combination with minoxidil significantly improved hair growth in mice.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

Kūlaris improved quality of life for acne sufferers without side effects.

Certain plant compounds can help prevent and treat a virus in pigs.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

Venlafaxine may cause paranoid delusions in some patients.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The FDA approved a new Pfizer drug for hair loss in teens.